Oncolix Inc. (fka ONCX)

[dabullishbear]

Every investor here is well aware of the fact that a clinical stage biopharma is going to sell shares in order to fund operations from now until they have a revenue generating drug. We aren't investing into Oncolix because of their current balance sheet, we are investing because of the potential of Prolanta. This is so simple and it boils down to Prolanta and nothing else. If the drug works, everyone here makes money, if it doesn't, no one makes money. Pointing out things that are normal for every company that is pre-revenue and trying to make a negative argument out of them is really really dumb. You have a better argument when comparing Prolanta vs Novartis' LFA102, but it's a weak argument at best as they aren't even close to similar.

I think it's time for some new material and maybe a new angle? Just some thoughts.